Latest period
$32.79M
YoY change
-8.0%
5Y CAGR
+33.6%
Peak year (2022)
$41.13M
Latest annual
$33.57M
Total Debt history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: $33.57M
Total Debt growth chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: -8.0%
Total Debt history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | $33.57M | -8.0% | −$2.92M | ||
| 2024 | $36.49M | -6.2% | −$2.43M | ||
| 2023 | $38.92M | -5.4% | −$2.21M | ||
| 2022 | $41.13M | +2636.6% | +$39.63M | ||
| 2021 | $1.50M | -80.9% | −$6.38M | ||
| 2020 | $7.88M | -7.7% | −$655.00K | ||
| 2019 | $8.54M | — | — |
- 2025$33.57M-8.0%
- 2024$36.49M-6.2%
- 2023$38.92M-5.4%
- 2022$41.13M+2636.6%
- 2021$1.50M-80.9%
- 2020$7.88M-7.7%
- 2019$8.54M—
Total Debt values are taken from Tango Therapeutics's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported total debt is $32.79M. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Tango Therapeutics (TNGX) total debt is $33.57M – declined 8.0% year-over-year.
Tango Therapeutics total debt has grown on net over the period, with a +33.6% compound annual growth rate over 2020–2025 (5 years).
The record annual total debt stands at $41.13M, reached in 2022; the historical low of $1.50M was recorded in 2021.
Tango Therapeutics Total Debt by Year
Tango Therapeutics Total Debt 2025: $33.57M
In 2025, Tango Therapeutics reported total debt of $33.57M, declined 8.0% below 2024.
Tango Therapeutics Total Debt 2024: $36.49M
Tango Therapeutics total debt in 2024 was $36.49M, declined 6.2% below 2023.
Tango Therapeutics Total Debt 2023: $38.92M
2023's total debt for Tango Therapeutics came in at $38.92M, declined 5.4% below 2022.
Tango Therapeutics Total Debt 2022: $41.13M
Tango Therapeutics posted total debt of $41.13M in 2022, surged 2636.6% from 2021. This figure represents the highest annual value in the available history.
Tango Therapeutics Total Debt 2021: $1.50M
Tango Therapeutics total debt in 2021 was $1.50M.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Total Debt
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation